April 2026
PreciSept completes initial preclinical animal study
PreciSept has completed its first in-vivo preclinical study. Results support the device's core mechanism of action across multiple crossing modalities. The study builds on earlier ex-vivo benchtop testing that validated the mechanical-first crossing approach.